Compile Data Set for Download or QSAR
maximum 50k data
Found 108 Enz. Inhib. hit(s) with all data for entry = 9857
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382491(CHEMBL2024114 | US10988455, Example 1(xlii))
Affinity DataKi:  0.145nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493753(US10988455, Example 1(lxxix))
Affinity DataKi:  0.447nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493769(US10988455, Example 1(clxxx))
Affinity DataKi:  1.26nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382491(CHEMBL2024114 | US10988455, Example 1(xlii))
Affinity DataKi:  1.38nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493775(US10988455, Example 1(ccxi))
Affinity DataKi:  1.82nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493770(US10988455, Example 1(clxxxi))
Affinity DataKi:  1.95nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493794(US10988455, Example 5(vii))
Affinity DataKi:  2.04nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382497(CHEMBL2021950 | US10988455, Example 1(xli))
Affinity DataKi:  2.09nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493776(US10988455, Example 1(ccxii))
Affinity DataKi:  2.19nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493747(US10988455, Example 1(li))
Affinity DataKi:  2.19nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493768(US10988455, Example 1(clxxix))
Affinity DataKi:  2.40nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382498(CHEMBL2024119 | US10988455, Example 1(ccix))
Affinity DataKi:  2.57nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493745(US10988455, Example 1(xliii))
Affinity DataKi:  2.88nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493798(US10988455, Example 5(x))
Affinity DataKi:  3.02nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493750(US10988455, Example 1(lxxii))
Affinity DataKi:  3.02nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493791(US10988455, Example 3(xxiv))
Affinity DataKi:  3.47nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493737(US10988455, Example 1(xv))
Affinity DataKi:  3.55nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382489(CHEMBL2024112 | US10988455, Example 1(xiii))
Affinity DataKi:  3.98nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493765(US10988455, Example 1(clxix))
Affinity DataKi:  3.98nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382496(CHEMBL2024120 | US10988455, Example 1(cxciii))
Affinity DataKi:  4.57nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493771(US10988455, Example 1(cxci))
Affinity DataKi:  5.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493749(US10988455, Example 1(lvi))
Affinity DataKi:  6.03nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493742(US10988455, Example 1(xxxv))
Affinity DataKi:  6.31nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382492(CHEMBL2024115 | US10988455, Example 5(viii))
Affinity DataKi:  7.76nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493756(US10988455, Example 1(xc))
Affinity DataKi:  8.51nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493789(US10988455, Example 3(xxi))
Affinity DataKi:  8.51nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382496(CHEMBL2024120 | US10988455, Example 1(cxciii))
Affinity DataKi:  8.51nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493798(US10988455, Example 5(x))
Affinity DataKi:  8.91nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493740(US10988455, Example 1(xxiv))
Affinity DataKi:  9.33nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493767(US10988455, Example 1(clxxvi))
Affinity DataKi:  9.33nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382495(CHEMBL2024118 | US10988455, Example 1(clviii))
Affinity DataKi:  10.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382492(CHEMBL2024115 | US10988455, Example 5(viii))
Affinity DataKi:  12.3nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493793(US10988455, Example 4(ii))
Affinity DataKi:  12.9nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493757(US10988455, Example 1(xcv))
Affinity DataKi:  13.8nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382497(CHEMBL2021950 | US10988455, Example 1(xli))
Affinity DataKi:  14.8nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493735(US10988455, Example 1(ix))
Affinity DataKi:  15.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493764(US10988455, Example 1(clix))
Affinity DataKi:  15.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50011296(CHEMBL3260728 | US10988455, Example 2(iv))
Affinity DataKi:  16.2nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493797(US10988455, Example 5(ix))
Affinity DataKi:  17nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493769(US10988455, Example 1(clxxx))
Affinity DataKi:  17.4nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493799(US10988455, Example 5(xi))
Affinity DataKi:  17.4nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493745(US10988455, Example 1(xliii))
Affinity DataKi:  18.2nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493775(US10988455, Example 1(ccxi))
Affinity DataKi:  19.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493735(US10988455, Example 1(ix))
Affinity DataKi:  20nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493776(US10988455, Example 1(ccxii))
Affinity DataKi:  20.9nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493797(US10988455, Example 5(ix))
Affinity DataKi:  24nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493760(US10988455, Example 1(cxxxiv))
Affinity DataKi:  24nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382498(CHEMBL2024119 | US10988455, Example 1(ccix))
Affinity DataKi:  25.1nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM50382494(CHEMBL2024117 | US10988455, Example 1(cliv))
Affinity DataKi:  27.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Heptares Therapeutics

US Patent
LigandPNGBDBM493768(US10988455, Example 1(clxxix))
Affinity DataKi:  30.2nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 108 total ) | Next | Last >>
Jump to: